ArticleFrontiers in neurology2018

Intravenous Administration of Bone Marrow-Derived Mesenchymal Stem Cell, but not Adipose Tissue-Derived Stem Cell, Ameliorated the Neonatal Hypoxic-Ischemic Brain Injury by Changing Cerebral Inflammatory State in Rat.

Yuichiro Sugiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.